Free Trial
→ We recommended Palantir in 2021, now we’re recommending this... (From Behind the Markets) (Ad) Free BSX Stock Alerts

Boston Scientific (BSX) Short Interest Ratio & Short Volume

Boston Scientific logo
$105.41 -0.26 (-0.24%)
Closing price 02/20/2025 03:59 PM Eastern
Extended Trading
$105.22 -0.19 (-0.18%)
As of 08:50 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Boston Scientific Short Interest Data

Boston Scientific (BSX) has a short interest of 10.45 million shares. This marks a -27.43% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.9, indicating that it would take 1.9 days of the average trading volume of 5.96 million shares to cover all short positions.

Current Short Interest
10,450,000 shares
Previous Short Interest
14,400,000 shares
Change Vs. Previous Month
-27.43%
Dollar Volume Sold Short
$1.07 billion
Short Interest Ratio
1.9 Days to Cover
Last Record Date
January 31, 2025
Outstanding Shares
1,475,780,000 shares
Percentage of Shares Shorted
0.71%
Today's Trading Volume
5,977,501 shares
Average Trading Volume
5,957,022 shares
Today's Volume Vs. Average
100%
Short Selling Boston Scientific?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Boston Scientific and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

BSX Short Interest Over Time

BSX Days to Cover Over Time

BSX Percentage of Float Shorted Over Time

Boston Scientific Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/31/202510,450,000 shares $1.07 billion -27.4%N/A1.9 $102.40
1/15/202514,400,000 shares $1.39 billion -0.8%N/A2.5 $96.87
12/31/202414,520,000 shares $1.30 billion +17.8%N/A2.5 $89.32
12/15/202412,330,000 shares $1.11 billion +0.7%N/A2.1 $90.11
11/30/202412,250,000 shares $1.11 billion +11.2%N/A2.1 $90.66
11/15/202411,020,000 shares $958.46 million -14.6%N/A1.8 $86.98
10/31/202412,910,000 shares $1.08 billion +14.2%N/A2.3 $84.02
10/15/202411,310,000 shares $981.37 million +3.6%N/A2 $86.77
9/30/202410,920,000 shares $915.10 million -10.5%N/A2 $83.80
9/15/202412,200,000 shares $1.02 billion +10.7%N/A2.2 $83.31
8/31/202411,020,000 shares $901.33 million +2.6%N/A2 $81.79
8/15/202410,740,000 shares $833.21 million -0.6%N/A1.9 $77.58
7/31/202410,800,000 shares $797.69 million -6.3%N/A1.8 $73.86
7/15/202411,530,000 shares $899.57 million +2.5%N/A1.9 $78.02
6/30/202411,250,000 shares $866.36 million -2.5%N/A1.9 $77.01
6/15/202411,540,000 shares $885.81 million -13.8%N/A1.9 $76.76
5/31/202413,380,000 shares $1.01 billion +8.5%N/A2.2 $75.59
5/15/202412,330,000 shares $917.97 million -11.6%N/A2 $74.45
4/30/202413,940,000 shares $1.00 billion +5.9%N/A2.2 $71.86
4/15/202413,160,000 shares $887.51 million +5.9%N/A2 $67.44
3/31/202412,430,000 shares $851.33 million +8.3%N/A1.9 $68.49
3/15/202411,480,000 shares $760.32 million +21.6%N/A1.8 $66.23
2/29/20249,440,000 shares $625.02 million -14.4%N/A1.5 $66.21
2/15/202411,030,000 shares $728.97 million +1.5%N/A1.7 $66.09
1/31/202410,870,000 shares $687.64 million -4.9%N/A1.6 $63.26
1/15/202411,430,000 shares $685.11 million +22.3%N/A1.7 $59.94
12/31/20239,350,000 shares $540.52 million -19.7%N/A1.3 $57.81
12/15/202311,640,000 shares $649.63 million +26.0%N/A1.6 $55.81
11/30/20239,240,000 shares $516.42 million -22.0%N/A1.2 $55.89
11/15/202311,850,000 shares $638.12 million +29.7%N/A1.4 $53.85
10/31/20239,140,000 shares $467.88 million -32.3%N/A1.1 $51.19
10/15/202313,490,000 shares $668.02 million -7.5%N/A1.6 $49.52
9/30/202314,580,000 shares $769.82 million +22.7%N/A1.9 $52.80
9/15/202311,880,000 shares $628.45 million -2.8%N/A1.6 $52.90
8/31/202312,220,000 shares $659.15 million +40.1%N/A1.7 $53.94
8/15/20238,720,000 shares $450.65 million +4.7%N/A1.2 $51.68
7/31/20238,330,000 shares $431.91 million +13.2%N/A1.1 $51.85
7/15/20237,360,000 shares $390.30 million -13.2%N/A0.9 $53.03
6/30/20238,480,000 shares $458.51 million -2.8%N/A1 $54.07
6/15/20238,720,000 shares $470.79 million -29.5%N/A1 $53.99
Why Buffett and 100 members of Congress are Piling into this One Investment (Ad)

This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.

Click here for the ticker >>>
5/31/202312,360,000 shares $636.29 million -23.0%N/A1.3 $51.48
5/15/202316,050,000 shares $861.56 million -10.7%N/A1.8 $53.68
4/30/202317,970,000 shares $936.60 million +16.4%N/A2.1 $52.12
4/15/202315,440,000 shares $799.33 million +1.9%N/A1.9 $51.77
3/31/202315,160,000 shares $758.45 million +5.9%N/A1.9 $50.03
3/15/202314,310,000 shares $686.45 million +12.8%N/A2 $47.97
2/28/202312,690,000 shares $592.88 million +29.9%N/A1.8 $46.72
2/15/20239,770,000 shares $462.02 million -26.2%N/A1.5 $47.29
1/31/202313,230,000 shares $611.89 million -15.3%N/A2 $46.25
1/15/202315,610,000 shares $726.33 million +10.6%N/A2.3 $46.53
12/30/202214,110,000 shares $652.87 million -1.7%N/A2.1 $46.27
12/15/202214,350,000 shares $664.69 million +8.8%N/A2.1 $46.32
11/30/202213,190,000 shares $597.11 million +0.2%N/A1.9 $45.27
11/15/202213,170,000 shares $558.67 million -5.3%N/A1.9 $42.42
10/31/202213,910,000 shares $599.66 million -8.6%N/A2 $43.11
10/15/202215,220,000 shares $608.50 million -8.8%N/A2.2 $39.98
9/30/202216,690,000 shares $646.40 million +3.7%N/A2.5 $38.73
9/15/202216,100,000 shares $679.42 million +5.9%N/A2.4 $42.20
8/31/202215,210,000 shares $613.12 million -9.8%N/A2.1 $40.31
8/15/202216,860,000 shares $710.65 million +22.6%N/A2.2 $42.15
7/31/202213,750,000 shares $564.44 million -14.3%N/A1.7 $41.05
7/15/202216,040,000 shares $602.30 million -2.4%N/A1.9 $37.55
6/30/202216,440,000 shares $612.72 million -13.6%N/A1.9 $37.27
6/15/202219,020,000 shares $685.29 million +25.3%1.4%2.2 $36.03
5/31/202215,180,000 shares $622.53 million +1.2%1.1%1.8 $41.01
5/15/202215,000,000 shares $594.90 million +21.5%1.1%1.7 $39.66
4/30/202212,350,000 shares $520.06 million +3.2%0.9%1.4 $42.11
4/15/202211,970,000 shares $529.67 million -23.6%0.9%1.3 $44.25
3/31/202215,670,000 shares $694.02 million +13.4%1.1%1.7 $44.29
3/15/202213,820,000 shares $589.56 million -21.5%1.0%1.5 $42.66
2/28/202217,600,000 shares $777.39 million -0.3%1.3%1.9 $44.17
2/15/202217,650,000 shares $776.78 million -3.8%1.3%1.9 $44.01
1/31/202218,340,000 shares $786.79 million +19.1%1.3%2 $42.90
1/15/202215,400,000 shares $690.84 million +1.9%1.1%1.9 $44.86
12/31/202115,120,000 shares $642.30 million +11.5%1.1%2 $42.48
12/15/202113,560,000 shares $545.65 million -7.8%1.0%1.8 $40.24
11/30/202114,700,000 shares $559.63 million -6.4%1.0%2.1 $38.07
11/15/202115,710,000 shares $649.45 million -26.0%1.1%2.4 $41.34
10/29/202121,220,000 shares $915.22 million -6.0%1.5%3.3 $43.13
10/15/202122,570,000 shares $979.54 million -5.1%1.6%3.6 $43.40
9/30/202123,790,000 shares $1.03 billion +15.8%1.7%3.7 $43.39
9/15/202120,540,000 shares $924.51 million +2.7%1.5%3.2 $45.01
8/31/202120,000,000 shares $903 million +19.0%1.4%3.2 $45.15
8/13/202116,810,000 shares $745.19 million +17.9%1.2%2.6 $44.33
7/30/202114,260,000 shares $650.26 million +15.5%1.0%2.2 $45.60
7/15/202112,350,000 shares $520.68 million -2.8%N/A1.9 $42.16
6/30/202112,710,000 shares $543.48 million -5.2%N/A1.8 $42.76
6/15/202113,400,000 shares $572.85 million +17.5%N/A1.9 $42.75
5/28/202111,400,000 shares $485.07 million -2.9%N/A1.6 $42.55
5/14/202111,740,000 shares $488.50 million -29.4%N/A1.5 $41.61
How You Could Invest in Elon’s ‘Final Move’ (Ad)

What if I told you Elon Musk's next big venture could leave Tesla and SpaceX in the dust? It may sound unbelievable - but it's true. Elon's new AI startup could redefine the industry and create 10 TIMES more American millionaires than Tesla ever did. This isn't just another AI story. It's what I'm calling Elon's "Final Move."

Click here to learn EXACTLY what to do >>>
4/30/202116,620,000 shares $732.94 million +13.8%N/A2 $44.10
4/15/202114,610,000 shares $579.58 million -3.2%N/A1.7 $39.67
3/31/202115,090,000 shares $587.91 million -15.1%N/A1.6 $38.96
3/15/202117,780,000 shares $690.75 million -0.2%N/A1.8 $38.85
2/26/202117,810,000 shares $706.52 million -2.3%N/A1.5 $39.67
2/12/202118,230,000 shares $708.60 million +26.8%N/A1.5 $38.87
1/29/202114,380,000 shares $522.57 million -6.6%N/A1.1 $36.34
1/15/202115,400,000 shares $556.86 million +2.2%N/A1.1 $36.16
12/31/202015,070,000 shares $535.74 million -7.8%N/A1.1 $35.55
12/15/202016,340,000 shares $546.57 million +33.7%N/A1.2 $33.45
11/30/202012,220,000 shares $410.59 million -5.8%N/A1 $33.60
11/15/202012,970,000 shares $492.60 million +6.6%N/A1.2 $37.98
10/30/202012,170,000 shares $407.70 million +5.6%N/A1.3 $33.50
10/15/202011,520,000 shares $467.94 million -10.8%N/A1.5 $40.62
9/30/202012,920,000 shares $493.67 million -20.5%N/A1.8 $38.21
9/15/202016,250,000 shares $666.58 million +9.5%N/A1.9 $41.02
8/31/202014,840,000 shares $608.74 million -9.9%N/A1.6 $41.02
8/14/202016,470,000 shares $644.97 million +5.2%N/A1.7 $39.16
7/31/202015,660,000 shares $604.01 million +5.2%N/A1.5 $38.57
7/15/202014,890,000 shares $546.46 million -12.8%N/A1.4 $36.70
6/30/202017,070,000 shares $599.33 million -8.4%N/A1.5 $35.11
6/15/202018,640,000 shares $668.62 million +9.3%N/A1.6 $35.87
5/29/202017,060,000 shares $648.11 million +52.3%N/A1.4 $37.99
5/15/202011,200,000 shares $390.10 million +8.6%N/A0.9 $34.83
4/30/202010,310,000 shares $386.42 million -14.1%N/A0.9 $37.48
4/15/202012,000,000 shares $417.48 million +21.7%N/A1 $34.79
3/31/20209,860,000 shares $363.83 million -31.1%N/A0.8 $36.90
3/13/202014,308,500 shares $526.98 million +25.2%N/A1.7 $36.83
2/28/202011,430,000 shares $295.24 million +9.2%N/A1.3 $25.83

BSX Short Interest - Frequently Asked Questions

What is Boston Scientific's current short interest?

Short interest is the volume of Boston Scientific shares that have been sold short but have not yet been covered or closed out. As of January 31st, traders have sold 10,450,000 shares of BSX short. Learn More on Boston Scientific's current short interest.

What is a good short interest ratio for Boston Scientific?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BSX shares currently have a short interest ratio of 2.0. Learn More on Boston Scientific's short interest ratio.

Which institutional investors are shorting Boston Scientific?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Boston Scientific: Wolverine Trading LLC, Squarepoint Ops LLC, Point72 Asset Management L.P., Nomura Holdings Inc., Millennium Management LLC, LMR Partners LLP, Jefferies Financial Group Inc., Group One Trading LLC, Eisler Capital Management Ltd., Cubist Systematic Strategies LLC, Caption Management LLC, Capstone Investment Advisors LLC, Citadel Advisors LLC, Balyasny Asset Management L.P., Bank of America Corp DE, BNP Paribas Financial Markets, Jane Street Group LLC, Parallax Volatility Advisers L.P., Two Sigma Securities LLC, Susquehanna International Group LLP, Hsbc Holdings PLC, HAP Trading LLC, Concourse Financial Group Securities Inc., PEAK6 LLC, Walleye Trading LLC, Walleye Capital LLC, Barclays PLC, Harbert Fund Advisors Inc., Capital Fund Management S.A., Wells Fargo & Company MN, JPMorgan Chase & Co., Garda Capital Partners LP, Fulcrum Asset Management LLP, Allianz Asset Management GmbH, Valeo Financial Advisors LLC, Genus Capital Management Inc., IMC Chicago LLC, Caas Capital Management LP, Portman Square Capital LLP, and JPMorgan Chase & Co.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Boston Scientific's short interest increasing or decreasing?

Boston Scientific saw a drop in short interest in January. As of January 31st, there was short interest totaling 10,450,000 shares, a drop of 27.4% from the previous total of 14,400,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Boston Scientific's short interest compare to its competitors?

Here is how the short interest of companies compare to Boston Scientific: Abbott Laboratories (1.06%), Intuitive Surgical, Inc. (1.18%), Stryker Co. (1.11%), Medtronic plc (1.10%), Becton, Dickinson and Company (0.94%), Edwards Lifesciences Co. (1.74%), IDEXX Laboratories, Inc. (2.42%), DexCom, Inc. (2.52%), ResMed Inc. (5.65%), STERIS plc (1.02%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks.

What does it mean to sell short Boston Scientific stock?

Short selling BSX is an investing strategy that aims to generate trading profit from Boston Scientific as its price is falling. BSX shares are trading down $0.26 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Boston Scientific?

A short squeeze for Boston Scientific occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BSX, which in turn drives the price of the stock up even further.

How often is Boston Scientific's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BSX, twice per month. The most recent reporting period available is January, 31 2025.



Related Companies
Short Interest Tools

This page (NYSE:BSX) was last updated on 2/21/2025 by MarketBeat.com Staff
From Our Partners
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
NVDA Crash Update
An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...
Chaikin Analytics | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
My 2025 AI Blueprint
I first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...
Weiss Ratings | Sponsored
Is Starlink Set For The Largest IPO In History?
He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...
Paradigm Press | Sponsored
Buy this AI Stock Before Elon’s Announcement
With Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...
InvestorPlace | Sponsored
America cannot power AI
There’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...
Porter & Company | Sponsored
Three new patents reveal Elon and Trump’s secret “Project America”
Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...
Timothy Sykes | Sponsored